6533b839fe1ef96bd12a6685
RESEARCH PRODUCT
Could allergen-specific immunotherapy benefit from the use of nanocarriers?
Joachim SalogaHannah PohlitHolger Freysubject
0301 basic medicinemedicine.medical_treatmentBiomedical EngineeringMedicine (miscellaneous)BioengineeringDevelopmentImmunoglobulin E03 medical and health sciencesDrug Delivery Systems0302 clinical medicineImmune systemmedicineHumansGeneral Materials ScienceAntigen deliverybiologybusiness.industrySpecific immunotherapyImmunotherapyAllergensmedicine.diseaseNanomedicine030104 developmental biology030228 respiratory systemDesensitization ImmunologicImmunologybiology.proteinNanoparticlesNanocarriersbusinessType I hypersensitivitydescription
Allergen-specific immunotherapy: challenges The total number of people suffering from allergic diseases increased dramatically during recent decades. Allergic reactions of the immediate type (type I hypersensitivity reactions according to classification by Coombs and Gell) involve an overreaction of the immune system and the formation of IgE
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2016-06-01 | Nanomedicine |